BMP — BMP Pharma Trading AG Share Price
0.000.00%
Last trade - 00:00- €30.98m
- €31.10m
- €0.00m
- 21
- 36
- 27
- 14
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.47 | ||
| Price to Tang. Book | 3.47 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 19,239.13 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -14.94% | ||
| Return on Equity | 32.69% | ||
| Operating Margin | -123188.82% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 0 | 0 | 0 | 0 | 0 | n/a | n/a | 7.72% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -45.07 | +1440.9 | -40.06 | +75.39 | +4.59 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
BMP Pharma Trading AG is a Germany-based holding company. The Company is primarily engaged in trade and distribution of active ingredients and raw materials for pharmaceuticals, food supplements, cosmetics and animal feeds. BMP Pharma operating in four divisions such as Pharmaceutical raw materials/active ingredients, Food and Function, Feed and Functions and Dermacosmetics. Pharmaceutical raw materials/active ingredients division supply pharmaceutical active ingredients and raw materials for the veterinary industry to obtain and trade with it and develops marketing strategies for mutual success with suppliers, partners and customers. The Food and Function division develops nutritional supplements for the fitness, training and athletics industries with raw materials. The Feed and Function division is pioneering the development of additives and premixes for animal feed. The Dermacosmetics division offers medical cosmetic institutes exclusive, inclusive products and care concepts.
Directors
- Wolfgang Westphalen CSU
- Bernd-Michael Joerss CEO (80)
- Sebastian Voigt VCH
- Henning Nau MGB
- Tobias Schulze SUB
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 6th, 2004
- Public Since
- April 21st, 2004
- No. of Employees
- 54
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Berlin Stock Exchange
- Shares in Issue
- 5,250,000
- Address
- Bornbarch 16, NORDERSTEDT, 22848
- Web
- https://www.bmp.ag/
- Phone
- +49 406455680
- Auditors
- ADKL AG
Upcoming Events for BMP
FAQ
What is the BMP Pharma Trading AG share price?
As of Today at 10:40 UTC, shares in BMP Pharma Trading AG are trading at €5.90. This share price information is delayed by 15 minutes.
How has the BMP Pharma Trading AG share price performed this year?
Shares in BMP Pharma Trading AG last closed at €5.90 and the price had moved by -1.67% over the past 365 days. In terms of relative price strength the BMP Pharma Trading AG share price has underperformed the FTSE Global All Cap Index by -6.01% over the past year.
What are the analyst and broker recommendations for BMP Pharma Trading AG?
There is no consensus recommendation for this security.
Find out moreWhat is the BMP Pharma Trading AG dividend yield?
The BMP Pharma Trading AG dividend yield is 8.14% based on the trailing twelve month period.
Does BMP Pharma Trading AG pay a dividend?
Last year, BMP Pharma Trading AG paid a total dividend of €0.48, and it currently has a trailing dividend yield of 8.14%.Looking ahead, shares in BMP Pharma Trading AG are due to go ex-dividend on 2025-07-18 and the next dividend pay date is 2025-07-22.
When does BMP Pharma Trading AG next pay dividends?
BMP Pharma Trading AG are due to go ex-dividend on 2025-07-18 and the next dividend pay date is 2025-07-22. The historic dividend yield on BMP Pharma Trading AG shares is currently 8.14%.
How do I buy BMP Pharma Trading AG shares?
To buy shares in BMP Pharma Trading AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of BMP Pharma Trading AG?
As of the previous close price of €5.90, shares in BMP Pharma Trading AG had a market capitalisation of €30.98m.
Where are BMP Pharma Trading AG shares listed?
Here are the trading details for BMP Pharma Trading AG:
- Country of listing: Germany
- Exchange: BER
- Ticker Symbol: BMP
What kind of share is BMP Pharma Trading AG?
Based on an overall assessment of its quality, value and momentum BMP Pharma Trading AG is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a BMP Pharma Trading AG share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the BMP Pharma Trading AG share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BMP Pharma Trading AG. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +22.02%.
As of the last closing price of €5.90, shares in BMP Pharma Trading AG were trading +8.62% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the BMP Pharma Trading AG PE Ratio?
The BMP Pharma Trading AG PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €5.90.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of BMP Pharma Trading AG?
BMP Pharma Trading AG's management team is headed by:
- Wolfgang Westphalen - CSU
- Bernd-Michael Joerss - CEO
- Sebastian Voigt - VCH
- Henning Nau - MGB
- Tobias Schulze - SUB